标题
The Evolving Role of Antifungal Susceptibility Testing
作者
关键词
-
出版物
PHARMACOTHERAPY
Volume 33, Issue 5, Pages 465-475
出版商
Wiley
发表日期
2013-04-01
DOI
10.1002/phar.1233
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints
- (2012) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine
- (2012) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Presence of anFKSMutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata
- (2012) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility
- (2012) Shawn R. Lockhart et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Correlation of Susceptibility of Cryptococcus neoformans to Amphotericin B with Clinical Outcome
- (2011) R. A. Larsen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans
- (2011) Nathan P. Wiederhold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroEchinocandin Susceptibility ofAspergillusIsolates from Patients Enrolled in the Transplant-Associated Infection Surveillance Network
- (2011) Shawn R. Lockhart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin
- (2011) J. L. Slater et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
- (2011) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Effects of Micafungin, Caspofungin, and Anidulafungin against a Difficult-To-Treat Fungal Opportunistic Pathogen, Candida glabrata
- (2011) Elisabetta Spreghini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients
- (2011) Peter F. Troke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method
- (2011) Michael A. Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria
- (2011) Michael A. Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
- (2011) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes
- (2011) D. N. Shah et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
- (2010) John R. Perfect et al. CLINICAL INFECTIOUS DISEASES
- Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods
- (2010) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Aspergillus Species to the Triazoles
- (2010) M. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Breakpoints for Susceptibility Testing Should Not Divide Wild-Type Distributions of Important Target Species
- (2009) M. C. Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints
- (2009) Paul E. Verweij et al. DRUG RESISTANCE UPDATES
- Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network
- (2009) J. W. Baddley et al. JOURNAL OF CLINICAL MICROBIOLOGY
- In vitro susceptibility testing in fungi: a global perspective on a variety of methods
- (2009) Cornelia Lass-Flörl et al. MYCOSES
- Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia
- (2008) J. W. Baddley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins
- (2008) M. C. Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility Testing
- (2008) M. C. Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infections Caused by Scedosporium spp.
- (2008) K. J. Cortez et al. CLINICAL MICROBIOLOGY REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started